These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 11185635)

  • 1. Pharmacokinetics of single-dose telmisartan 120 mg given during and between hemodialysis in subjects with severe renal insufficiency: comparison with healthy volunteers.
    Stangier J; Su CA; Brickl R; Franke H
    J Clin Pharmacol; 2000 Dec; 40(12 Pt 1):1365-72. PubMed ID: 11185635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and safety of intravenous and oral telmisartan 20 mg and 120 mg in subjects with hepatic impairment compared with healthy volunteers.
    Stangier J; Su CA; Schöndorfer G; Roth W
    J Clin Pharmacol; 2000 Dec; 40(12 Pt 1):1355-64. PubMed ID: 11185634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absorption, metabolism, and excretion of intravenously and orally administered [14C]telmisartan in healthy volunteers.
    Stangier J; Schmid J; Türck D; Switek H; Verhagen A; Peeters PA; van Marle SP; Tamminga WJ; Sollie FA; Jonkman JH
    J Clin Pharmacol; 2000 Dec; 40(12 Pt 1):1312-22. PubMed ID: 11185629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of orally and intravenously administered telmisartan in healthy young and elderly volunteers and in hypertensive patients.
    Stangier J; Su CA; Roth W
    J Int Med Res; 2000; 28(4):149-67. PubMed ID: 11014323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of repeated oral doses of amlodipine and amlodipine plus telmisartan in healthy volunteers.
    Stangier J; Su CA
    J Clin Pharmacol; 2000 Dec; 40(12 Pt 1):1347-54. PubMed ID: 11185633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple-dose pharmacokinetics of telmisartan and of hydrochlorothiazide following concurrent administration in healthy subjects.
    Young CL; Dias VC; Stangier J
    J Clin Pharmacol; 2000 Dec; 40(12 Pt 1):1323-30. PubMed ID: 11185630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of telmisartan on the steady-state pharmacokinetics of digoxin in healthy male volunteers.
    Stangier J; Su CA; Hendriks MG; van Lier JJ; Sollie FA; Oosterhuis B; Jonkman JH
    J Clin Pharmacol; 2000 Dec; 40(12 Pt 1):1373-9. PubMed ID: 11185636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose response and safety of telmisartan in patients with mild to moderate hypertension.
    Smith DH; Matzek KM; Kempthorne-Rawson J
    J Clin Pharmacol; 2000 Dec; 40(12 Pt 1):1380-90. PubMed ID: 11185637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the safety and efficacy of telmisartan and enalapril, with the potential addition of frusemide, in moderate-renal failure patients with mild-to-moderate hypertension.
    Hannedouche T; Chanard J; Baumelou B;
    J Renin Angiotensin Aldosterone Syst; 2001 Dec; 2(4):246-54. PubMed ID: 11881131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety, efficacy, and pharmacokinetics of telmisartan in pediatric patients with hypertension.
    Wells TG; Portman R; Norman P; Haertter S; Davidai G; Fei Wang
    Clin Pediatr (Phila); 2010 Oct; 49(10):938-46. PubMed ID: 20724342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Telmisartan pharmacokinetics in Japanese renal transplant recipients.
    Miura M; Satoh S; Inoue K; Saito M; Habuchi T; Suzuki T
    Clin Chim Acta; 2009 Jan; 399(1-2):83-7. PubMed ID: 18838068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of telmisartan in healthy Chinese subjects after oral administration of two dosage levels.
    Zhang P; Zhang Y; Chen X; Li R; Yin J; Zhong D
    Arzneimittelforschung; 2006; 56(8):569-73. PubMed ID: 17009837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic and pharmacogenomic profiles of telmisartan after the oral microdose and therapeutic dose.
    Ieiri I; Nishimura C; Maeda K; Sasaki T; Kimura M; Chiyoda T; Hirota T; Irie S; Shimizu H; Noguchi T; Yoshida K; Sugiyama Y
    Pharmacogenet Genomics; 2011 Aug; 21(8):495-505. PubMed ID: 21691256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic interaction of telmisartan with s-amlodipine: an open-label, two-period crossover study in healthy Korean male volunteers.
    Noh YH; Lim HS; Kim MJ; Kim YH; Choi HY; Sung HR; Jin SJ; Lim J; Bae KS
    Clin Ther; 2012 Jul; 34(7):1625-35. PubMed ID: 22721873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analyzing rich data using different methods provided by NONMEM: pharmacokinetics of telmisartan following intravenous infusion to healthy volunteers.
    Wallenstein GC; Stangier J; Ludden TM
    Pharm Res; 1999 May; 16(5):772-6. PubMed ID: 10350024
    [No Abstract]   [Full Text] [Related]  

  • 16. Steady-state pharmacodynamics and pharmacokinetics of warfarin in the presence and absence of telmisartan in healthy male volunteers.
    Stangier J; Su CA; Hendriks MG; van Lier JJ; Sollie FA; Oosterhuis B; Jonkman JH
    J Clin Pharmacol; 2000 Dec; 40(12 Pt 1):1331-7. PubMed ID: 11185631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of acetaminophen and ibuprofen when coadministered with telmisartan in healthy volunteers.
    Stangier J; Su CA; Fraunhofer A; Tetzloff W
    J Clin Pharmacol; 2000 Dec; 40(12 Pt 1):1338-46. PubMed ID: 11185632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of candesartan cilexetil in patients with renal or hepatic impairment.
    de Zeeuw D; Remuzzi G; Kirch W
    J Hum Hypertens; 1997 Sep; 11 Suppl 2():S37-42. PubMed ID: 9331004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative pharmacokinetics of a fixed-dose combination vs concomitant administration of telmisartan and S-amlodipine in healthy adult volunteers.
    Oh M; Park SE; Ghim JL; Choi YK; Shim EJ; Shin JG; Kim EY
    Drug Des Devel Ther; 2017; 11():3543-3550. PubMed ID: 29270003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of renal and vascular protective effects between telmisartan and amlodipine in hypertensive patients with chronic kidney disease with mild renal insufficiency.
    Nakamura T; Inoue T; Suzuki T; Kawagoe Y; Ueda Y; Koide H; Node K
    Hypertens Res; 2008 May; 31(5):841-50. PubMed ID: 18712038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.